Albemarle Growth and Economic Outlook
Adjusted EBITDA - Continuing Operations (twelve months ended)
Twelve Months Ended
($ in thousands)
Net income attributable to Albemarle Corporation
Sep 30, 2022
Dec 31, 2022
Mar 31, 2023
Jun 30, 2023
1,553,547
$
2,689,816
$
3,675,013
$
3,918,283
$
Sep 30, 2023
3,323,601
Depreciation and amortization
283,515
300,841
321,538
343,630
371,362
Non-recurring and other unusual items (excluding items
associated with interest expense)
215,768
28,671
(14,691)
198,217
228,689
Interest and financing expenses
104,240
122,973
121,916
106,084
105,725
Income tax expense
381,510
390,588
587,021
540,990
335,501
Non-operating pension and OPEB items
(77,752)
(57,032)
(51,151)
(45,501)
(39,854)
Adjusted EBITDA
$
2,460,828 $
3,475,857 $
4,639,646 $
5,061,703 $
4,325,024
Net sales
Adjusted EBITDA margin
5,593,330 $
7,320,104 $ 8,772,628
9,663,225 $
9,882,016
44 %
47 %
53%
52 %
44 %
See above for a reconciliation of adjusted EBITDA and pro-forma adjusted EBITDA, the non-GAAP financial measures, to Net income attributable to Albemarle Corporation, the most directly comparable
financial measure calculated and reported in accordance with GAAP.
See above for a reconciliation of pro-forma net sales, the non-GAAP financial measure, to net sales, the most directly comparable financial measure calculated and reported in accordance with GAAP.
AAlbemarle
38
38View entire presentation